|
Re: Thoughts on PX: Calm down
|
2
|
Resverlogix Corp.
|
Mar 15, 2019 02:04PM
|
|
Re: ACC 2019 Abstracts
|
2
|
Resverlogix Corp.
|
Mar 19, 2019 12:10PM
|
|
Re: ACC 2019 Abstracts
|
2
|
Resverlogix Corp.
|
Mar 19, 2019 12:18PM
|
|
Re: ACC 2019 Abstracts
|
2
|
Resverlogix Corp.
|
Mar 19, 2019 01:25PM
|
|
Re: Biogen/Eisai Scrap Aducanumab
|
1
|
Resverlogix Corp.
|
Mar 25, 2019 10:27AM
|
|
Re: DECLARE TIMI-58 w/ prior MI as BETonMACE proxy?
|
1
|
Resverlogix Corp.
|
Mar 29, 2019 11:07AM
|
|
Re: DECLARE TIMI-58 w/ prior MI as BETonMACE proxy?
|
1
|
Resverlogix Corp.
|
Mar 29, 2019 11:34AM
|
|
AACR
|
5
|
Zenith Epigenetics
|
Mar 30, 2019 06:07AM
|
|
Re: What else can RVX treat that we don’t know about yet?
|
7
|
Resverlogix Corp.
|
Mar 30, 2019 09:44PM
|
|
Re: What else can RVX treat that we don’t know about yet?
|
2
|
Resverlogix Corp.
|
Mar 30, 2019 10:01PM
|
|
Re: What else can RVX treat that we don’t know about yet?
|
5
|
Resverlogix Corp.
|
Mar 30, 2019 10:16PM
|
|
Re: Reata
|
3
|
Resverlogix Corp.
|
Apr 03, 2019 01:57PM
|
|
Re: Reata
|
1
|
Resverlogix Corp.
|
Apr 03, 2019 02:00PM
|
|
Re: MOA of Apabetalone - only affects sick patients
|
2
|
Resverlogix Corp.
|
Apr 15, 2019 08:46AM
|
|
Re: MOA of Apabetalone - only affects sick patients
|
5
|
Resverlogix Corp.
|
Apr 15, 2019 09:42AM
|
|
Potential Market Size
|
2
|
Resverlogix Corp.
|
Apr 18, 2019 11:52AM
|
|
Re: Potential Market Size
|
1
|
Resverlogix Corp.
|
Apr 18, 2019 12:27PM
|
|
Re: Classifying/taxonomy mCRPC patients
|
4
|
Zenith Epigenetics
|
Apr 20, 2019 03:44PM
|
|
Brd2 And Inflammation
|
3
|
Resverlogix Corp.
|
Apr 23, 2019 10:46AM
|
|
Bromoscan
|
2
|
Resverlogix Corp.
|
Apr 25, 2019 07:16AM
|
